Cytotoxic T cells transduced with chimeric anti-CD19 receptors prevent engraftment of primary lymphoblastic leukemia in vivo.
Landmeier
S
S
Altvater
B
B
Pscherer
S
S
Meltzer
J
J
Sebire
N
N
Pule
M
M
Vera
J
J
Hotfilder
M
M
Juergens
H
H
Vormoor
J
J
Rossig
C
C
D000818:Animals; D018941:Antigens, CD19 / Q000276:immunology* / Q000378:metabolism; D001853:Bone Marrow / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D005434:Flow Cytometry; D020544:Graft vs Leukemia Effect / Q000276:immunology*; D006801:Humans; D016219:Immunotherapy, Adoptive; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D011971:Receptors, Immunologic / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000637:transplantation*
D018941:Antigens, CD19; D011971:Receptors, Immunologic